Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0e9bca1120ab9d2f65b138f53e3eda4d http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c16d2144a81bfa32a665dca1e93c3d37 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4188 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5011 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57484 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-18 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4188 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
filingDate |
2016-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_00af20b29e5c1517a149b24a597933f6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e810718ad095ccd00365b02222be8cce http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f419582931dc58187b2edff1743b7e2e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a1730bc4882e9bcc04f77d0c76ebabc3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4bd935c3ae99ca982a1c5f3fcb108810 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_38fd905c380a8207cbb5522f1a5da1e6 |
publicationDate |
2018-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20180009639-A |
titleOfInvention |
Pharmaceutical Composition for Treating or Preventing Brain Tumor Comprising Midkine inhibitor |
abstract |
Provided are a pharmaceutical composition for treating and/or preventing brain tumor comprising Midkine inhibitors or a combination of Midkine inhibitors and Temozolomide as an active ingredient, and uses for overcoming resistance against Temozolomide treatment of Midkine inhibitors and/or radiation therapy. |
priorityDate |
2016-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |